Pharma & Biotech

Add to MyProactive

Tiziana Life Sciences Ltd -

Tiziana Life Sciences reports reduced brain inflammation in Alzheimer’s patient treated with nasal foralumab

3 weeks ago

Protalix Biotherapeutics Inc -

Protalix eyes Phase II gout trial later this year following solid Q1 revenue growth

3 weeks ago

Protalix is developing innovative treatments for rare diseases with its proprietary ProCellEx plant cell expression system

Protalix Biotherapeutics is developing innovative treatments for rare diseases with its proprietary ProCellEx plant cell expression system

3 weeks ago

Immunic CMO on Celiac Disease Awareness Month, potential of IMU-856

Immunic CMO on Celiac Disease Awareness Month, potential of IMU-856

3 weeks ago

Genflow Biosciences PLC - Genflow Biosciences raises new capital as dog gene trial advances

Genflow Biosciences raises new capital as dog gene trial advances

3 weeks ago

Orthocell Ltd - Orthocell expands US sales rollout of Remplir, beating distributor targets

Orthocell expands US sales rollout of Remplir, beating distributor targets

3 weeks, 1 day ago

Lisata Therapeutics Inc -

Lisata eyes key trial milestones in 2025 as certepetide development gains momentum

3 weeks, 1 day ago

cancer cells

Lisata Therapeutics is pioneering new treatments for solid tumors

3 weeks, 1 day ago

Tonix showcases promising gastric cancer data at AACR Conference

Tonix showcases promising gastric cancer data at AACR Conference

3 weeks, 1 day ago

Teva Pharmaceutical Industries -

Teva Pharma climbs as earnings impress

3 weeks, 2 days ago

Novo Nordisk -

Novo Nordisk investors relieved after expected guidance cut

3 weeks, 2 days ago

Immunic eyes Phase 3 after MS disability gains in Phase 2 CALLIPER trial

Immunic eyes Phase 3 after MS disability gains in Phase 2 CALLIPER trial

3 weeks, 2 days ago

Novo Nordisk -

Novo Nordisk shares rise despite cut to 2025 outlook

3 weeks, 2 days ago

Tiziana Life Sciences Ltd - Tiziana reports encouraging results for nasal MS drug in early study

Tiziana shares surge on encouraging results for nasal MS drug in early study

3 weeks, 3 days ago

Tiziana Life Sciences Ltd - Tiziana shares surge 21% on promising multiple sclerosis data

Tiziana shares surge 21% on promising multiple sclerosis data

3 weeks, 3 days ago

Medicus Pharma to acquire Antev, advancing opportunity in prostate health solutions

Medicus Pharma to acquire Antev, advancing opportunity in prostate health solutions

3 weeks, 4 days ago

Autonomix Medical reports promising results in first-in-human trial for novel cancer pain therapy

Autonomix Medical reports promising results in first-in-human trial for novel cancer pain therapy

3 weeks, 4 days ago

Race Oncology Ltd -

Race Oncology bolsters clinical leadership with senior appointments to drive RC220 program

3 weeks, 5 days ago

Genflow Biosciences PLC -

Genflow Biosciences moves forward on MASH trial - ICYMI

3 weeks, 5 days ago

OKYO Pharma Ltd - OKYO moves toward FDA talks after eye drug trial – ICYMI

OKYO moves toward FDA talks after eye drug trial – ICYMI

4 weeks ago

	
		OSZAR »